News Releases - Corporate News | Merck Newsroom Home

News Releases - Corporate News

Merck to Present at the UBS Global Healthcare Conference
5/17/13 3:45 pm EDT
Global Health, Development and Business Leaders Announce New Innovative Financing Partnership to Deliver Essential Health Supplies More Quickly and Efficiently
5/17/13 8:30 am EDT
Merck Prices $ 6.5 Billion Debt Offering
5/15/13 6:29 pm EDT
Merck for Mothers Launches Initiative in India to Reduce the Number of Women Dying During Pregnancy and Childbirth
5/14/13 4:23 pm EDT
Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference
5/14/13 9:15 am EDT
GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck’s HPV Vaccine, Available to Developing Countries through UNICEF Tender
5/9/13 7:20 am EDT
Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet
5/8/13 8:30 am EDT
Merck and Celebrity Chef Art Smith “Cook Up a Recipe” for Better Type 2 Diabetes Management
5/7/13 10:33 am EDT
FDA Approves Merck’s LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol
5/3/13 3:06 pm EDT
Merck Announces First-Quarter 2013 Financial Results
5/1/13 7:00 am EDT
Supplemental_Earnings_Package_1Q13.pdf (189.7 KB)

RSS

Patients & Caregivers
Healthcare Professionals
- EngageZone
- The Merck Manual
- Merck Medicus
- Authorized Distributors
- Clinical Trials
- Supplier Diversity
Media & Investors
Job Seekers
Company Statements

Copyright © 2009- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
Privacy
Terms of Use
Site Map

Business Wire NewsHQ℠